Pashtoon Kasi: The largest series to date on POL-E or POLD1 metastatic Colorectal Cancer and the use of immunotherapy
Pashtoon Kasi shared a post on LinkedIn:
“The largest series to date on POL-E or POLD1 (proofreading-deficient) metastatic Colorectal Cancer and the use of immunotherapy.
Tumors MSS but have a very high TMB (ultra-hyper-mutated – TMB > 100 Mut/Mb).”
Read further.
Source: Pashtoon Kasi/LinkedIn
Pashtoon Kasi is a medical oncologist and researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Within his roles at Weill Cornell Medicine, he holds the positions of Director for Colorectal Cancer Research and Precision Medicine Director for Liquid Biopsy Research at the Englander Institute of Precision Medicine. Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023